KLRS — KALARIS THERAPEUTICS INC
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
As of Q2 2026, 56 SEC-registered investment managers reported holding KLRS (KALARIS THERAPEUTICS INC) in their latest 13F filings, with a combined reported value of $73.76M across 18.12M shares. That is +2.9% by share count (+506.63K shares) versus the previous quarter, while reported value moved -27.4%. Ownership is concentrated: the five largest holders account for 86.0% of reported value and the top ten for 91.7%.
Compared with the prior quarter, 11 opened new positions, 18 added to existing stakes, 8 trimmed, 14 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
Major shareholders of KALARIS THERAPEUTICS INC (KLRS) include Samsara BioCapital, LLC, RTW INVESTMENTS, LP, Paradigm Biocapital Advisors LP, ranked by reported 13F value among the 88 institutional holders on this page.
KLRS is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 37 | 1.79M | $5.19M | -15.9% |
| Q2 2026 | 56 | 18.12M | $73.76M | +2.9% |
| Q1 2026 | 59 | 18.64M | $107.53M | +3.5% |
| Q4 2025 | 51 | 18.00M | $151.88M | +12.7% |
| Q3 2025 | 32 | 13.25M | $76.57M | +1.4% |
| Q2 2025 | 30 | 13.42M | $35.82M | -1.9% |
| Q1 2025 | 33 | 13.89M | $111.54M | — |
Over the 7 quarters shown, institutional share counts decreased 87% in aggregate (Q1 2025 → Q3 2026); the largest single-quarter swing was Q4 2025 (+12.7%).
Top Institutional Holders (Q3 2026) — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 356.56K | $1.03M | 0.02% | Reduce | |
| 330.93K | $956.38K | 0.00% | Reduce | |
| 176.86K | $511.13K | 0.00% | Add | |
| 110.19K | $318.44K | 0.00% | Reduce | |
| 101.50K | $293.32K | 0.00% | Add | |
| 97.49K | $281.75K | 0.16% | Hold | |
| 78.86K | $228.01K | 0.00% | Reduce | |
| 58.62K | $169.41K | 0.00% | Add | |
| 51.21K | $148.00K | 0.00% | Add | |
| 47.55K | $137.43K | 0.00% | Reduce | |
| 40.00K | $115.60K | 0.00% | Hold | |
| 40.00K | $115.60K | 0.01% | Hold | |
| 35.68K | $103.11K | 0.00% | Add | |
| 33.84K | $97.80K | 0.07% | Add | |
| 26.77K | $77.37K | 0.00% | Reduce | |
| 25.56K | $73.00K | 0.00% | Add | |
| 23.60K | $68.21K | 0.04% | Add | |
| 23.29K | $67.30K | 0.00% | Add | |
| 22.50K | $65.03K | 0.00% | New | |
| 19.59K | $56.63K | 0.00% | New | |
| 18.95K | $54.76K | 0.00% | Reduce | |
| 17.39K | $50.26K | 0.00% | Hold | |
| 15.96K | $46.12K | 0.00% | Hold | |
| 14.00K | $40.46K | 0.03% | Add | |
| 12.62K | $36.49K | 0.00% | Reduce |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 12.88M | $52.43M | 4.31% | Reduce | |
| 1.30M | $5.29M | 0.04% | Hold | |
| 572.69K | $2.33M | 0.01% | Hold | |
| 435.80K | $1.77M | 0.04% | Hold | |
| 398.71K | $1.62M | 0.00% | Add | |
| 360.00K | $1.47M | 0.23% | Hold | |
| 262.13K | $1.07M | 0.00% | Add | |
| 149.35K | $607.86K | 0.00% | Add | |
| 139.20K | $566.55K | 0.00% | Add | |
| 114.04K | $464.29K | 0.00% | New | |
| 114.04K | $464.29K | 0.00% | Add | |
| 100.00K | $407.00K | 0.02% | Hold | |
| 100.00K | $407.00K | 0.00% | Hold | |
| 97.49K | $396.80K | 0.26% | Hold | |
| 97.16K | $395.46K | 0.00% | Reduce | |
| 95.77K | $389.79K | 0.00% | New | |
| 92.26K | $375.50K | 0.01% | Hold | |
| 80.30K | $326.81K | 0.31% | New | |
| 72.33K | $294.37K | 0.00% | Add | |
| 66.18K | $269.35K | 0.00% | Add | |
| 54.44K | $221.58K | 0.00% | Add | |
| 40.00K | $162.80K | 0.01% | Hold | |
| 40.00K | $162.80K | 0.02% | Hold | |
| 39.63K | $161.28K | 0.01% | New | |
| 38.77K | $157.81K | 0.00% | Reduce |
Q1 2026 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 12.95M | $74.71M | 7.26% | Hold | |
| 1.30M | $7.50M | 0.07% | Hold | |
| 700.00K | $4.04M | 0.08% | Hold | |
| 572.69K | $3.27M | 0.01% | Add | |
| 435.80K | $2.51M | 0.07% | Hold | |
| 360.00K | $2.08M | 0.25% | Hold | |
| 295.77K | $1.72M | 1.08% | Add | |
| 255.35K | $1.47M | 0.00% | New | |
| 135.59K | $782.33K | 0.55% | Reduce | |
| 118.89K | $685.98K | 0.00% | Add | |
| 110.50K | $637.60K | 0.00% | Add | |
| 100.00K | $577.00K | 0.04% | Hold | |
| 100.00K | $577.00K | 0.00% | Hold | |
| 97.49K | $562.53K | 0.42% | Hold | |
| 92.26K | $532.35K | 0.01% | Hold | |
| 87.55K | $505.34K | 0.00% | Add | |
| 87.43K | $504.45K | 0.01% | Add | |
| 67.88K | $391.66K | 0.00% | Reduce | |
| 66.15K | $381.69K | 0.00% | Reduce | |
| 59.53K | $343.51K | 0.00% | New | |
| 59.53K | $343.51K | 0.00% | New | |
| 52.68K | $303.99K | 0.00% | Add | |
| 45.00K | $259.65K | 0.02% | Reduce | |
| 40.00K | $230.80K | 0.01% | Hold | |
| 40.00K | $230.80K | 0.03% | Hold |
Q4 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 12.95M | $109.28M | 11.28% | Add | |
| 1.30M | $10.97M | 0.11% | New | |
| 700.00K | $5.91M | 0.15% | New | |
| 435.80K | $3.68M | 0.11% | Add | |
| 403.55K | $3.40M | 0.01% | New | |
| 360.00K | $3.04M | 0.35% | New | |
| 292.79K | $2.47M | 0.00% | Add | |
| 139.90K | $1.18M | 1.17% | New | |
| 100.00K | $844.00K | 0.07% | New | |
| 100.00K | $844.00K | 0.00% | Reduce | |
| 97.49K | $822.84K | 0.63% | New | |
| 92.26K | $778.68K | 0.02% | New | |
| 88.44K | $746.40K | 0.00% | New | |
| 87.75K | $740.62K | 0.00% | Reduce | |
| 82.95K | $700.14K | 0.05% | Hold | |
| 82.65K | $697.60K | 0.00% | Add | |
| 80.59K | $680.18K | 0.03% | New | |
| 72.88K | $615.07K | 0.00% | Add | |
| 42.05K | $354.93K | 0.30% | New | |
| 40.00K | $337.60K | 0.01% | Hold | |
| 40.00K | $337.60K | 0.05% | Hold | |
| 38.45K | $324.55K | 0.00% | Reduce | |
| 34.30K | $289.52K | 0.00% | Add | |
| 33.11K | $279.48K | 0.00% | New | |
| 30.00K | $253.20K | 0.00% | New |
Q3 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 11.45M | $66.17M | 8.64% | Hold | |
| 418.24K | $2.42M | 0.09% | Add | |
| 318.26K | $1.84M | 0.07% | Add | |
| 241.10K | $1.39M | 0.01% | New | |
| 203.05K | $1.17M | 0.00% | Add | |
| 112.75K | $651.70K | 0.00% | Add | |
| 82.95K | $479.48K | 0.05% | Hold | |
| 64.55K | $373.15K | 0.00% | Add | |
| 40.38K | $233.39K | 0.00% | Add | |
| 40.17K | $232.20K | 0.00% | Reduce | |
| 40.00K | $231.20K | 0.01% | New | |
| 40.00K | $231.20K | 0.04% | New | |
| 24.92K | $144.06K | 0.00% | Reduce | |
| 24.92K | $144.06K | 0.00% | Reduce | |
| 24.92K | $144.03K | 0.00% | Add | |
| 22.61K | $130.69K | 0.00% | Add | |
| 22.50K | $130.05K | 0.00% | New | |
| 22.46K | $129.85K | 0.00% | New | |
| 17.39K | $100.52K | 0.01% | Hold | |
| 14.12K | $81.58K | 0.00% | Hold | |
| 10.00K | $57.80K | 0.00% | New | |
| 7.81K | $45.12K | 0.00% | Hold | |
| 5.25K | $30.36K | 0.00% | Add | |
| 578 | $3.34K | 0.00% | Reduce | |
| 268 | $1.55K | 0.00% | New |
Q2 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 11.45M | $30.57M | 6.25% | Hold | |
| 360.86K | $963.49K | 0.05% | Add | |
| 360.00K | $961.20K | 0.21% | Reduce | |
| 317.79K | $848.50K | 0.07% | Reduce | |
| 282.59K | $754.50K | 0.04% | Hold | |
| 129.84K | $346.67K | 0.00% | Add | |
| 96.75K | $258.32K | 0.00% | Add | |
| 82.95K | $221.49K | 0.02% | Hold | |
| 59.09K | $157.78K | 0.00% | Add | |
| 54.09K | $144.43K | 0.00% | Add | |
| 54.09K | $144.43K | 0.00% | Add | |
| 38.16K | $101.88K | 0.00% | Add | |
| 25.48K | $68.04K | 0.00% | Reduce | |
| 24.23K | $64.70K | 0.00% | New | |
| 20.28K | $54.15K | 0.00% | Reduce | |
| 17.39K | $46.43K | 0.00% | Hold | |
| 14.12K | $37.69K | 0.00% | Hold | |
| 10.71K | $28.60K | 0.00% | Hold | |
| 7.81K | $20.84K | 0.00% | Hold | |
| 4.12K | $10.99K | 0.00% | Reduce | |
| 2.63K | $7.02K | 0.00% | New | |
| 2.15K | $5.75K | 0.00% | Add | |
| 1.96K | $5.24K | 0.00% | Add | |
| 634 | $1.69K | 0.00% | Hold | |
| 273 | $729 | 0.00% | Reduce |
New Positions (Q2 2026)
- GEODE CAPITAL MANAGEMENT, LLC 114.04K sh · $464.29K
- Citadel Advisors 95.77K sh · $389.79K
- Verdad Advisers, LP 80.30K sh · $326.81K
- Pale Fire Capital SE 39.63K sh · $161.28K
- Trexquant Investment LP 29.74K sh · $121.03K
- Quadrature Capital Ltd 16.53K sh · $67.27K
- DIMENSIONAL FUND ADVISORS LP 15.96K sh · $64.99K
- Virtu Financial LLC 10.85K sh · $44.00K
- Sigma Planning Corp 10.17K sh · $41.38K
- Integrated Wealth Concepts LLC 5.00K sh · $20.35K
- Caitong International Asset Management Co., Ltd 7 sh · $28
Fully Exited (vs previous quarter)
- Paradigm Biocapital Advisors LP sold 700.00K sh · $4.04M
- Propel Bio Management, LLC sold 295.77K sh · $1.72M
- Kalehua Capital Management LLC sold 135.59K sh · $782.33K
- Simplify Asset Management Inc. sold 87.43K sh · $504.45K
- Millennium Management sold 59.53K sh · $343.51K
- MILLENNIUM MANAGEMENT LLC sold 59.53K sh · $343.51K
- 683 Capital Management, LLC sold 45.00K sh · $259.65K
- STATE STREET CORP sold 26.51K sh · $152.96K
- Qube Research & Technologies Ltd sold 11.10K sh · $64.06K
- Johnson Financial Group, Inc. sold 10.00K sh · $57.70K
- Citigroup Inc sold 8.70K sh · $50.22K
- ROYAL BANK OF CANADA sold 103 sh · $1.00K
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|---|
| Siren, L.L.C. | 356.56K | 435.80K | 435.80K | 435.80K | 318.26K | 282.59K | 282.59K |
| VANGUARD CAPITAL MANAGEMENT LLC | 330.93K | 398.71K | 255.35K | — | — | — | — |
| Renaissance Technologies | 176.86K | 149.35K | 66.15K | 87.75K | 112.75K | 96.75K | 19.25K |
| UBS Group AG | 110.19K | 262.13K | 6.18K | 2.69K | 5.25K | 4.12K | 9.26K |
| RAYMOND JAMES FINANCIAL INC | 101.50K | 97.16K | 118.89K | 88.44K | — | 2.63K | — |
| WHI TRUST Co LLC | 97.49K | 97.49K | 97.49K | 97.49K | — | — | — |
| Geode Capital Management | 78.86K | 114.04K | 87.55K | 82.65K | 64.55K | 25.48K | 26.79K |
| BlackRock Inc | 58.62K | 54.44K | 36.04K | 38.45K | 40.38K | 38.16K | 27.51K |
| STATE STREET CORP | 51.21K | — | 26.51K | 25.41K | 22.61K | 10.71K | 10.71K |
| VANGUARD FIDUCIARY TRUST CO | 47.55K | 66.18K | 36.72K | — | — | — | — |
| Belpointe Asset Management LLC | 40.00K | 40.00K | 40.00K | 40.00K | 40.00K | — | — |
| Fortis Capital Advisors, LLC | 40.00K | 40.00K | 40.00K | 40.00K | 40.00K | — | — |
| Connor, Clark & Lunn Investment Management Ltd. | 35.68K | 30.01K | 13.65K | 10.16K | — | — | — |
| Stonepine Capital Management, LLC | 33.84K | 30.12K | 20.40K | — | — | — | — |
| Morgan Stanley | 26.77K | 72.33K | 38.34K | 27.95K | 24.92K | 1.96K | 1.30K |
| HRT FINANCIAL LP | 25.56K | 13.72K | 11.62K | — | — | — | — |
| WealthTrust Asset Management, LLC | 23.60K | 20.42K | 12.42K | — | — | — | — |
| Quadrature Capital Ltd | 23.29K | 16.53K | — | — | — | — | — |
| Empowered Funds, LLC | 22.50K | — | — | — | — | — | — |
| JANE STREET GROUP, LLC | 19.59K | — | — | 33.11K | — | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details
FAQ
Which funds hold KLRS?
As of 2026-Q2, 56 institutional funds reported holding KLRS (KALARIS THERAPEUTICS INC) in SEC 13F filings, with a combined reported value of $73.76M.
How many shares of KLRS do institutions own?
13F filers reported 18.12M shares of KLRS, worth $73.76M in aggregate at the end of 2026-Q2.
Is institutional ownership of KLRS rising or falling?
Share counts moved +2.9% versus the prior quarter — accumulation.
Who are the top institutional holders of KLRS?
The largest 13F holders are Samsara BioCapital, LLC, RTW INVESTMENTS, LP, Paradigm Biocapital Advisors LP, Vanguard Group, TANG CAPITAL MANAGEMENT LLC; the top 25 are ranked at the top of this page.
Who are the major shareholders of KALARIS THERAPEUTICS INC?
The major shareholders of KALARIS THERAPEUTICS INC (KLRS) by reported 13F value are Samsara BioCapital, LLC, RTW INVESTMENTS, LP, Paradigm Biocapital Advisors LP, Vanguard Group, TANG CAPITAL MANAGEMENT LLC, among 88 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.